Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-10-10

Clinical Trial Update: Prevention of Cefoperazone-induced Coagulopathy [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update investigating prevention of cefoperazone-induced coagulopathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • cefoperazone (cefoperazone)

Snippet

Sponsor: Helwan University | Conditions: Antibiotic Side Effect | Phase 4 | Status: COMPLETED